Clinical Certificate


Date: May 2020
Venue: Victoria and Albert Hotel, Water St, Manchester, M3 4JQ
Accommodation: Victoria and Albert Hotel, Water St, Manchester, M3 4JQ
(accommodation is bookable separately when you complete the online booking form)
Organised by: Professor Jo Neill and Dr Richard Drake


Programme to be confirmed

Last edited 11th March 2019

Learning Objectives

At the end of this module, the attendees will:

  • Be aware of current theories of the causes and neurochemistry of schizophrenia
  • Know the pharmacology of conventional and atypical drugs
  • Be aware of the clinical assessment of therapeutic and adverse effects
  • Have an opinion about relative benefits of conventional and atypical drugs
  • Be updated on guidelines and the social context of drug prescribing in schizophrenia
  • Have had an opportunity to discuss difficult management problems with colleagues and experts

This module is eligible for 11 CPD hours which are subject to peer group review.

For further details contact Susan Chandler, BAP Executive Officer:

Feedback from 2018 Module

"Excellent course – very well organized, presentations by superb speakers on a single illness. A really in-depth course for schizophrenia"

"A truly maximum value for money and time course. The focus on science and research makes the talks fascinating and compelling"

"Very useful, I will encourage higher trainees in psychiatry to attend this"

"Very well structured meeting; stimulating with excellent speakers. I feel inspired!"

"Another fantastic BAP module. Very helpful and relevant"